Showing all 4 results
Cinnarizine Tablets
FreeTechnical & Manufacturing Specifications
Formulated for consistent release kinetics and long-term chemical stability.
Technical Metric Specification Standard Active Ingredient Cinnarizine BP / USP / IP Dosage Form Immediate Release Tablets Available Strengths 25 mg (Vestibular) / 75 mg (Cerebrovascular) HS Code 3004.90.39 (Other CNS drugs) / 2933.59.90 Stability Validated for Zone IVb (Tropical) export markets Lamotrigine Tablets
FreeProduct Composition & Available Strengths
Because Lamotrigine demands highly delicate, low-dose introductory titration to ensure patient dermatological safety, we manufacture the full compendial strength matrix.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Lamotrigine USP / BP / IP 25 mg Oral Solid Uncoated / Dispersible Tablet Dermatological Intro Titration: Mandatory low-dose baseline format utilized exclusively for the critical initial 2-week dose-escalation phase. Lamotrigine USP / BP / IP 50 mg Oral Solid Uncoated / Dispersible Tablet Intermediate Step-Up Dosing: Step-up strength calibrated for weeks 3 and 4 of therapy to safely approach steady-state plasma metrics. Lamotrigine USP / BP / IP 100 mg Oral Solid Compressed Tablet Standard Maintenance Block: First-line international standard strength for adult maintenance monotherapy in epilepsy and bipolar stabilization. Lamotrigine USP / BP / IP 200 mg Oral High-Potency Solid Tablet Maximal Saturation Maintenance: High-strength configuration calibrated for advanced refractory partial seizures and combination therapies. Lorazepam Tablet
FreeProduct Composition & Available Strengths
We supply Lorazepam across the complete, internationally standardized therapeutic spectrum to allow for safe dose titration and exact behavioral control.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Target Lorazepam USP / BP / IP 0.5 mg Oral / Sublingual Micro-Tablet Mild Anxiety & Pediatric Titration: For delicate introductory dosing and generalized anxiety management. Lorazepam USP / BP / IP 1.0 mg Oral / Sublingual Micro-Tablet Foundation Anxiolytic / Insomnia: Standard baseline dosage for acute panic control and pre-operative sedation. Lorazepam USP / BP / IP 2.0 mg Oral High-Potency Solid Tablet Critical Care Stabilization: For intensive management of acute manic states, alcohol withdrawal delirium, and status epilepticus. Phenobarbital Tablets
FreePhenobarbitone Tablets IP
Each Uncoated tablet contains :
Phenobarbitone IP 30 mg
Excipients q.sPhenobarbitone Tablets IP 60 mg
Phenobarbital Tablets IP 60 mg
Each Uncoated tablet contains :
Phenobarbitone IP 60 mg
Phenobarbital
Excipients q.sPhenobarbital Tablets BP
Each Uncoated tablet contains :
Phenobarbital BP 30 mgPhenobarbital Tablets BP 60 mg
Each Uncoated tablet contains :
Phenobarbital BP 60 mg Excipients q.sPHENOBARBITAL TABLETS BP 90 MG Each Uncoated tablet contains : Phenobarbital BP 90 mg
Excioients 0 QSPhenobarbital Tablets BP 100 mg
Each Uncoated tablet contains :
Phenobarbital BP 100 mg Excipients -QSUsage: – To control seizures
Category: – Anti Hypertensive / Cardiac Drugs
Therapeutic category: – Hypertensive
